1. Home
  2. AVDL vs EXTR Comparison

AVDL vs EXTR Comparison

Compare AVDL & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.51

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Extreme Networks Inc.

EXTR

Extreme Networks Inc.

HOLD

Current Price

$15.96

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
EXTR
Founded
2015
1996
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
AVDL
EXTR
Price
$21.51
$15.96
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$18.38
$21.80
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
03-02-2026
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$248,517,000.00
$1,181,108,000.00
Revenue This Year
$65.47
$12.45
Revenue Next Year
$30.88
$7.33
P/E Ratio
N/A
$267.38
Revenue Growth
79.88
14.31
52 Week Low
$6.38
$10.10
52 Week High
$23.57
$22.89

Technical Indicators

Market Signals
Indicator
AVDL
EXTR
Relative Strength Index (RSI) 56.85 37.87
Support Level $21.45 $15.40
Resistance Level $21.60 $16.39
Average True Range (ATR) 0.08 0.39
MACD -0.05 0.00
Stochastic Oscillator 48.78 37.50

Price Performance

Historical Comparison
AVDL
EXTR

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

Share on Social Networks: